# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
UnitedHealth's OptumRx will implement a new pricing model, OptumRx Clear Trend Guarantee, starting next year.
Most items in the Well Market line are priced between $2.99 to $8.99
Argus Research analyst Chris Graja maintains CVS Health (NYSE:CVS) with a Buy and lowers the price target from $100 to $80.